Craigo J, Montelaro R
Viruses. 2013; 5(12):2963-76.
PMID: 24316675
PMC: 3967156.
DOI: 10.3390/v5122963.
Craigo J, Ezzelarab C, Cook S, Chong L, Horohov D, Issel C
PLoS One. 2013; 8(6):e66093.
PMID: 23785473
PMC: 3682429.
DOI: 10.1371/journal.pone.0066093.
Craigo J, Barnes S, Zhang B, Cook S, Howe L, Issel C
Retrovirology. 2009; 6:95.
PMID: 19843328
PMC: 2770520.
DOI: 10.1186/1742-4690-6-95.
Craigo J, Li F, Steckbeck J, Durkin S, Howe L, Cook S
J Virol. 2005; 79(5):2666-77.
PMID: 15708986
PMC: 548432.
DOI: 10.1128/JVI.79.5.2666-2677.2005.
Chung C, Mealey R, McGuire T
Virology. 2004; 327(1):144-54.
PMID: 15327905
PMC: 3342308.
DOI: 10.1016/j.virol.2004.06.035.
Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
Mealey R, Leib S, Pownder S, McGuire T
J Virol. 2004; 78(17):9295-305.
PMID: 15308724
PMC: 506964.
DOI: 10.1128/JVI.78.17.9295-9305.2004.
Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.
Mealey R, Zhang B, Leib S, Littke M, McGuire T
Virology. 2003; 313(2):537-52.
PMID: 12954220
PMC: 3342690.
DOI: 10.1016/s0042-6822(03)00344-1.
A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.
Li F, Craigo J, Howe L, Steckbeck J, Cook S, Issel C
J Virol. 2003; 77(13):7244-53.
PMID: 12805423
PMC: 164776.
DOI: 10.1128/jvi.77.13.7244-7253.2003.
Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
Howe L, Leroux C, Issel C, Montelaro R
J Virol. 2002; 76(21):10588-97.
PMID: 12368301
PMC: 136617.
DOI: 10.1128/jvi.76.21.10588-10597.2002.
Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
Hammond S, Li F, McKeon Sr B, Cook S, Issel C, Montelaro R
J Virol. 2000; 74(13):5968-81.
PMID: 10846078
PMC: 112093.
DOI: 10.1128/jvi.74.13.5968-5981.2000.
Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
Leroux C, Issel C, Montelaro R
J Virol. 1997; 71(12):9627-39.
PMID: 9371627
PMC: 230271.
DOI: 10.1128/JVI.71.12.9627-9639.1997.
Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.
Hammond S, Cook S, Lichtenstein D, Issel C, Montelaro R
J Virol. 1997; 71(5):3840-52.
PMID: 9094660
PMC: 191535.
DOI: 10.1128/JVI.71.5.3840-3852.1997.
Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR.
Langemeier J, Cook S, Cook R, Rushlow K, Montelaro R, Issel C
J Clin Microbiol. 1996; 34(6):1481-7.
PMID: 8735102
PMC: 229046.
DOI: 10.1128/jcm.34.6.1481-1487.1996.
Molecular biology and pathogenesis of animal lentivirus infections.
Clements J, Zink M
Clin Microbiol Rev. 1996; 9(1):100-17.
PMID: 8665473
PMC: 172884.
DOI: 10.1128/CMR.9.1.100.
Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
Lichtenstein D, Issel C, Montelaro R
J Virol. 1996; 70(6):3346-54.
PMID: 8648664
PMC: 190205.
DOI: 10.1128/JVI.70.6.3346-3354.1996.
Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses.
Sellon D, Walker K, Russell K, Perry S, Covington P, Fuller F
J Virol. 1996; 70(1):590-4.
PMID: 8523576
PMC: 189850.
DOI: 10.1128/JVI.70.1.590-594.1996.
The immunopathogenesis of equine infectious anemia virus.
Sellon D, Fuller F, McGuire T
Virus Res. 1994; 32(2):111-38.
PMID: 8067050
PMC: 7134051.
DOI: 10.1016/0168-1702(94)90038-8.
Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.
Cook R, Berger S, Rushlow K, McManus J, Cook S, Harrold S
J Virol. 1995; 69(3):1493-9.
PMID: 7853482
PMC: 188739.
DOI: 10.1128/JVI.69.3.1493-1499.1995.
Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus.
Chong Y, Ball J, Issel C, Montelaro R, Rushlow K
J Virol. 1991; 65(2):1013-8.
PMID: 1846180
PMC: 239850.
DOI: 10.1128/JVI.65.2.1013-1018.1991.
In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).
Rwambo P, Issel C, Hussain K, Montelaro R
Arch Virol. 1990; 111(3-4):275-80.
PMID: 1693846
DOI: 10.1007/BF01311062.